mevalonic acid and Cardiomegaly

mevalonic acid has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, B; Dai, DP; Ding, J; Hu, SJ; Mou, Y; Wu, HD; Yang, J; Zhao, CZ; Zhao, XM	1
Adachi, S; Isobe, M; Ito, H; Kitajima, S; Maejima, Y; Morikawa-Futamatsu, K; Suzuki, J; Tamamori-Adachi, M	1

Other Studies

2 other study(ies) available for mevalonic acid and Cardiomegaly

Article	Year
Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling. Scientific reports, 2016, 12-23, Volume: 6 Topics: Animals; Aorta, Abdominal; Blood Pressure; Calcium; Cardiomegaly; Down-Regulation; Geranyltranstransferase; Male; Mevalonic Acid; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monomeric GTP-Binding Proteins; Myocardium; ras Proteins; rhoA GTP-Binding Protein; RNA Interference; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Remodeling	2016
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Life sciences, 2006, Aug-29, Volume: 79, Issue:14 Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger	2006

Article

Year

Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling.

Scientific reports, 2016, 12-23, Volume: 6

Topics: Animals; Aorta, Abdominal; Blood Pressure; Calcium; Cardiomegaly; Down-Regulation; Geranyltranstransferase; Male; Mevalonic Acid; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monomeric GTP-Binding Proteins; Myocardium; ras Proteins; rhoA GTP-Binding Protein; RNA Interference; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Remodeling

2016

HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.

Life sciences, 2006, Aug-29, Volume: 79, Issue:14

Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger

2006